Cargando…
Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
There is a need for new combination regimens for tuberculosis. Identifying synergistic drug combinations can avoid toxic side effects and reduce treatment times. Using a fluorescent rifampicin conjugate, we demonstrated that synergy between cell wall inhibitors and rifampicin was associated with inc...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Microbiology Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470358/ https://www.ncbi.nlm.nih.gov/pubmed/32974492 http://dx.doi.org/10.1099/acmi.0.000006 |